These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 15772107)

  • 1. Incorporation of tumor shape into an assessment of spatial heterogeneity for human sarcomas imaged with FDG-PET.
    O'Sullivan F; Roy S; O'Sullivan J; Vernon C; Eary J
    Biostatistics; 2005 Apr; 6(2):293-301. PubMed ID: 15772107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A statistical measure of tissue heterogeneity with application to 3D PET sarcoma data.
    O'Sullivan F; Roy S; Eary J
    Biostatistics; 2003 Jul; 4(3):433-48. PubMed ID: 12925510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A statistical modeling approach to the analysis of spatial patterns of FDG-PET uptake in human sarcoma.
    O'Sullivan F; Wolsztynski E; O'Sullivan J; Richards T; Conrad EU; Eary JF
    IEEE Trans Med Imaging; 2011 Dec; 30(12):2059-71. PubMed ID: 21724502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sarcoma tumor FDG uptake measured by PET and patient outcome: a retrospective analysis.
    Eary JF; O'Sullivan F; Powitan Y; Chandhury KR; Vernon C; Bruckner JD; Conrad EU
    Eur J Nucl Med Mol Imaging; 2002 Sep; 29(9):1149-54. PubMed ID: 12192559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positron emission tomography/computed tomography with 18fluoro-deoxyglucose in the detection of local recurrence and distant metastases of pediatric sarcoma.
    Arush MW; Israel O; Postovsky S; Militianu D; Meller I; Zaidman I; Sapir AE; Bar-Shalom R
    Pediatr Blood Cancer; 2007 Dec; 49(7):901-5. PubMed ID: 17252575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of positron emission tomography in localized extremity soft tissue sarcoma treated with neoadjuvant chemotherapy.
    Schuetze SM; Rubin BP; Vernon C; Hawkins DS; Bruckner JD; Conrad EU; Eary JF
    Cancer; 2005 Jan; 103(2):339-48. PubMed ID: 15578712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. (F-18) fluorodeoxyglucose positron emission tomography as a predictor of pathologic grade and other prognostic variables in bone and soft tissue sarcoma.
    Folpe AL; Lyles RH; Sprouse JT; Conrad EU; Eary JF
    Clin Cancer Res; 2000 Apr; 6(4):1279-87. PubMed ID: 10778952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative [F-18]fluorodeoxyglucose positron emission tomography in pretreatment and grading of sarcoma.
    Eary JF; Conrad EU; Bruckner JD; Folpe A; Hunt KJ; Mankoff DA; Howlett AT
    Clin Cancer Res; 1998 May; 4(5):1215-20. PubMed ID: 9607579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of glucose metabolic activity is more accurate than change in size at predicting histopathologic response to neoadjuvant therapy in high-grade soft-tissue sarcomas.
    Evilevitch V; Weber WA; Tap WD; Allen-Auerbach M; Chow K; Nelson SD; Eilber FR; Eckardt JJ; Elashoff RM; Phelps ME; Czernin J; Eilber FC
    Clin Cancer Res; 2008 Feb; 14(3):715-20. PubMed ID: 18245531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positron emission tomography for staging of pediatric sarcoma patients: results of a prospective multicenter trial.
    Völker T; Denecke T; Steffen I; Misch D; Schönberger S; Plotkin M; Ruf J; Furth C; Stöver B; Hautzel H; Henze G; Amthauer H
    J Clin Oncol; 2007 Dec; 25(34):5435-41. PubMed ID: 18048826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of FDG positron emission tomography in conjunction with MR imaging for evaluating therapy response in patients with musculoskeletal sarcomas.
    Bredella MA; Caputo GR; Steinbach LS
    AJR Am J Roentgenol; 2002 Nov; 179(5):1145-50. PubMed ID: 12388489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positron emission tomography-based assessment of metabolic gradient and other prognostic features in sarcoma.
    Wolsztynski E; O'Sullivan F; Keyes E; O'Sullivan J; Eary JF
    J Med Imaging (Bellingham); 2018 Apr; 5(2):024502. PubMed ID: 29845091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promises and challenges of positron emission tomography for assessment of sarcoma in daily clinical practice.
    van de Luijtgaarden AC; de Rooy JW; de Geus-Oei LF; van der Graaf WT; Oyen WJ
    Cancer Imaging; 2008 Oct; 8 Spec No A(Spec Iss A):S61-8. PubMed ID: 18852082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of positron emission tomography in sarcomas.
    Schuetze SM
    Curr Opin Oncol; 2006 Jul; 18(4):369-73. PubMed ID: 16721133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluorine-18-fluorodeoxyglucose PET imaging of soft-tissue sarcoma.
    Nieweg OE; Pruim J; van Ginkel RJ; Hoekstra HJ; Paans AM; Molenaar WM; Koops HS; Vaalburg W
    J Nucl Med; 1996 Feb; 37(2):257-61. PubMed ID: 8667056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic activity measured on PET/CT correlates with clinical outcomes in patients with limb and girdle sarcomas.
    Skamene SR; Rakheja R; Dahlstrom KR; Roberge D; Nahal A; Charest M; Turcotte R; Hickeson M; Freeman C
    J Surg Oncol; 2014 Apr; 109(5):410-4. PubMed ID: 24310279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective evaluation of soft tissue masses and sarcomas using fluorodeoxyglucose positron emission tomography.
    Lucas JD; O'Doherty MJ; Cronin BF; Marsden PK; Lodge MA; McKee PH; Smith MA
    Br J Surg; 1999 Apr; 86(4):550-6. PubMed ID: 10215835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accuracy of 18F fluorodeoxyglucose positron emission tomography/computed tomography in staging of pediatric sarcomas.
    Tateishi U; Hosono A; Makimoto A; Sakurada A; Terauchi T; Arai Y; Imai Y; Kim EE
    J Pediatr Hematol Oncol; 2007 Sep; 29(9):608-12. PubMed ID: 17805034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FDG PET/CT findings of epithelioid sarcoma in a pediatric patient.
    Chen YW; Huang MY; Chang CC; Lee CS; Liao YM; Chiu SS; Chang TT
    Clin Nucl Med; 2007 Nov; 32(11):898-901. PubMed ID: 18075436
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of fluorine-18-FDG PET and technetium-99m-MIBI SPECT in evaluation of musculoskeletal sarcomas.
    Garcia R; Kim EE; Wong FC; Korkmaz M; Wong WH; Yang DJ; Podoloff DA
    J Nucl Med; 1996 Sep; 37(9):1476-9. PubMed ID: 8790197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.